Short Sellers Shy Away From Big Biotech
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Health and Healthcare
All Health and Healthcare Articles
Newest first · Page 47
Eyenovia Sees the Bigger Picture With New Licensing Deal
Eyenovia shares soared on Tuesday after the company announced an exclusive license agreement with Artic Vision.
5 Speculative Biotechs With 50% to 300% Implied Upside
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
Good News for C Diff Sufferers and Seres Therapeutics Investors
Seres Therapeutics shares more than tripled early on Monday after the firm announced positive late-stage results for its C. difficile infection study.
Investors Cheer AnPac Bio’s Coronavirus Developments
AnPac Bio-Medical Science shares surged higher on Friday after the company reaffirmed its status as a COVID-19 stock.
Biogen Has Potentially Great News in the Fight Against Alzheimer’s
The world may be focused on COVID-19 this year, but the battle against Alzheimer’s disease continues with no effective treatments. Biogen hopes to remedy that unfortunate situation.
Denali Therapeutics Takes Next Big Step in Treating Parkinson’s
Denali Therapeutics announced early Thursday that it would be progressing its Parkinson’s treatment into late-stage studies in collaboration with Biogen.
Novavax Bulls Keep Charging as More COVID-19 Results Come Out
Novavax shares hit another all-time high on Wednesday after the company announced positive results from its early stage COVID-19 vaccine study.
5 Large Biotech and Pharma Stocks Are Dirt Cheap, and Not Because of COVID-19
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be inexpensive…
How the COVID-19 Pandemic Drove Q2 Earnings at CVSÂ
Pharmacy and health insurer CVS handily beat expected earnings and revenue estimates for the second quarter.
Is Regneron’s COVID-19 Animal Study Giving More Creedence to Antibody Treatments?
Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug combination on Monday.
What You Need to Know About Alterity Therapeutics’ Tuesday Move
Alterity Therapeutics stock more than doubled on Tuesday after the company announced new data for its lead drug candidate for the treatment of multiple system atrophy.
Is European Update Overshadowing Amarin’s Lackluster Earnings?
Amarin reported its latest quarterly results on Tuesday morning and gave an update on the most recent developments with its blockbuster drug Vascepa.
The Nasty Surprise From Eastman Kodak
All those investors who were buying into the hype that Kodak will be a major player in making materials for generic drugs with a big government loan are being reminded just how chasing news…
CymaBay Pulls Off Another Win With PBC Liver Disease Study
CymaBay Therapeutics posted a huge gain to start off the week after the company reported results from a late-stage clinical study for the treatment of primary biliary cholangitis.